Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

A study has found that Ozempic may reverse signs of a disease that contributes to 2,000,000 deaths per year. New research has ...

Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...

An international study led by the director of Virginia Commonwealth University’s liver institute suggests that the substance ...

An international study led by the director of Virginia Commonwealth University’s liver institute suggests that ...

Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

Research revealed that medications widely used for diabetes and obesity may offer significant benefits for patients with ...

A major clinical trial reveals Wegovy a popular weight loss drug also treats serious liver disease MASH—reducing liver inflammation and scarring in most patients ...

Viking's leading drug candidate could be a blockbuster in the weight loss market, which experts believe could grow to $150 ...